$1.515
-0.015[-0.98%]
Last update: 3:10PM Get Real Time Here
Ocuphire Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ocuphire Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/13/2024 | AM | OCUP | Q1 | -$0.28 | -$0.09 | — | — | $1.75M | $5.00M | — | — | Get Alert |
03/08/2024 | AM | OCUP | Q4 | $1.63 | -$0.05 | -$0.21 | -320.00% | $39.85M | $5.35M | $1.69M | -68.39% | Get Alert |
11/13/2023 | AM | OCUP | Q3 | -$0.22 | -$0.22 | $0.25 | 213.64% | $0.00 | $3.02M | $11.94M | 295.20% | Get Alert |
08/11/2023 | AM | OCUP | Q2 | -$0.25 | -$0.23 | -$0.24 | -4.35% | $0.00 | $2.42M | $3.67M | 51.82% | Get Alert |
05/15/2023 | AM | OCUP | Q1 | -$0.35 | -$0.15 | -$0.28 | -86.67% | $0.00 | $2.95M | $1.75M | -40.71% | Get Alert |
03/30/2023 | AM | OCUP | Q4 | -$0.35 | $0.97 | $1.63 | 68.04% | $0.00 | $29.44M | $39.85M | 35.36% | Get Alert |
11/04/2022 | PM | OCUP | Q3 | -$0.25 | -$0.29 | -$0.22 | 24.14% | $489.00K | — | $0.00 | — | Get Alert |
08/12/2022 | AM | OCUP | Q2 | -$0.52 | — | -$0.25 | — | $0.00 | — | $0.00 | — | Get Alert |
05/13/2022 | AM | OCUP | Q1 | -$0.47 | — | -$0.35 | — | $0.00 | — | $0.00 | — | Get Alert |
03/24/2022 | AM | OCUP | Q4 | -$2.46 | -$0.29 | -$0.35 | -20.69% | $0.00 | — | $0.00 | — | Get Alert |
11/12/2021 | AM | OCUP | Q3 | -$0.33 | -$0.36 | -$0.25 | 30.56% | $0.00 | — | $489.00K | — | Get Alert |
08/12/2021 | AM | OCUP | Q2 | -$0.43 | -$0.37 | -$0.52 | -40.54% | $0.00 | — | $0.00 | — | Get Alert |
05/07/2021 | AM | OCUP | Q1 | -$0.93 | -$0.71 | -$0.47 | 33.80% | $0.00 | — | $0.00 | — | Get Alert |
Ocuphire Pharma (OCUP) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on March 8, 2024 for Q4.
The Actual EPS was $-0.21, which missed the estimate of $-0.05.
The Actual Revenue was $1.7M, which missed the estimate of $5.3M.
Browse earnings estimates, EPS, and revenue on all stocks.